| Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization (NCT01035853) | University of Jena | 2009-12-01 |
| Osteopathic Treatment in Adult Patients With Cystic Fibrosis (NCT01293019) | Assistance Publique - Hôpitaux de Paris | 2009-11-05 |
| Study of VX-770 and Rifampin in Healthy Male Subjects (NCT01018368) | Vertex Pharmaceuticals Incorporated | 2009-11-01 |
| Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis (NCT01094704) | University of North Carolina, Chapel Hill | 2009-11-01 |
| I Change Adherence & Raise Expectations (NCT01232478) | Johns Hopkins University | 2009-10-01 |
| MD2Me - Texting to Promote Chronic Disease Management (NCT01253733) | Huang, Jeannie, M.D. | 2009-10-01 |
| A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy Volunteers (NCT00999531) | Gilead Sciences | 2009-10-01 |
| Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects (NCT01078740) | CF Therapeutics Development Network Coordinating Center | 2009-10-01 |
| 28 Day Repeat Dose in Cystic Fibrosis Patients (NCT00903201) | GlaxoSmithKline | 2009-09-28 |
| Study of Ataluren (PTC124™) in Cystic Fibrosis (NCT00803205) | PTC Therapeutics | 2009-09-08 |
| Probiotics on Intestinal Inflammation in Cystic Fibrosis (NCT01961661) | Federico II University | 2009-09-01 |
| Needs in Education for Pulmonary or Cardiopulmonary Transplanted Cystic Fibrosis Patients (NCT01285895) | Nantes University Hospital | 2009-09-01 |
| A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® (NCT01111383) | Chiesi Farmaceutici S.p.A. | 2009-09-01 |
| Effect of Hypertonic Saline on Mucus Clearance in Children Ages 5-12 With Cystic Fibrosis (NCT01031706) | University of North Carolina, Chapel Hill | 2009-09-01 |
| A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers (NCT00951522) | Gilead Sciences | 2009-09-01 |
| Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects (NCT00966602) | Vertex Pharmaceuticals Incorporated | 2009-09-01 |
| Safety and Efficacy of Inhaled OligoG CF-5/20 for the Treatment Cystic Fibrosis (NCT00970346) | AlgiPharma AS | 2009-09-01 |
| Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen (NCT01710449) | Hal C Charles | 2009-09-01 |
| Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation (NCT00953706) | Vertex Pharmaceuticals Incorporated | 2009-09-01 |
| Open Label Extension to Bridging Study CTBM100C2303 (NCT00982930) | Novartis Pharmaceuticals | 2009-08-12 |
| Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation (NCT00909727) | Vertex Pharmaceuticals Incorporated | 2009-08-01 |
| Volatile Organic Compounds in Cystic Fibrosis (NCT01379040) | Landon Pediatric Foundation | 2009-08-01 |
| Natural History of Bronchiectasis (NCT00943514) | National Heart, Lung, and Blood Institute (NHLBI) | 2009-08-01 |
| Microbial Community Composition and Metabolism in Cystic Fibrosis (NCT00954018) | Boston Children's Hospital | 2009-08-01 |
| Molecular Phenotypes for Cystic Fibrosis Lung Disease (NCT01116414) | University of North Carolina, Chapel Hill | 2009-07-01 |
| Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ? (NCT00945347) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2009-07-01 |
| Comparison Between RTX (Biphasic Cuirass Ventilator) and Physiotherapy in Cystic Fibrosis Patients (NCT00908505) | Hadassah Medical Organization | 2009-07-01 |
| Building Adherence to Live With And Navigate my Cystic Fibrosis (CF) Experience (NCT01013896) | Johns Hopkins University | 2009-07-01 |
| Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant Patients (NCT00908830) | University of Michigan | 2009-06-01 |
| Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation (NCT00909532) | Vertex Pharmaceuticals Incorporated | 2009-06-01 |
| A Study of Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo (NCT00918957) | Novartis Pharmaceuticals | 2009-06-01 |
| Representations of Transplantation in Patients and in Health Care Professionals (NCT01285882) | Nantes University Hospital | 2009-06-01 |
| Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF) (NCT00880100) | Forest Laboratories | 2009-04-01 |
| "Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients" (NCT00840333) | Amgen | 2009-04-01 |
| RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum (NCT00843817) | University Hospital, Tours | 2009-04-01 |
| Infant Study of Inhaled Saline in Cystic Fibrosis (NCT00709280) | CF Therapeutics Development Network Coordinating Center | 2009-04-01 |
| A Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® (NCT00885365) | Chiesi Farmaceutici S.p.A. | 2009-04-01 |
| Evaluation of Bronchial Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) (NCT00906568) | Johann Wolfgang Goethe University Hospital | 2009-04-01 |
| Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis (NCT00775528) | Solvay Pharmaceuticals | 2009-04-01 |
| Study of Long-term Treatment With Hypertonic Saline in Patients With Cystic Fibrosis (NCT01377792) | Adelaida Lamas Ferreiro | 2009-03-01 |
| Study of VX-809 in Cystic Fibrosis Subjects With the ∆F508-CFTR Gene Mutation (NCT00865904) | Vertex Pharmaceuticals Incorporated | 2009-03-01 |
| Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642) (NCT00846781) | Merck Sharp & Dohme LLC | 2009-02-01 |
| Fecal Calprotectin in Cystic Fibrosis (NCT00863694) | Medical College of Wisconsin | 2009-02-01 |
| Open Label Safety Study of DCI-1020 in Pediatric Cystic Fibrosis (CF) Patients (NCT00663975) | Digestive Care, Inc. | 2009-02-01 |
| FDG-PET Imaging in Young Cystic Fibrosis Patients (NCT00846053) | Washington University School of Medicine | 2009-02-01 |
| Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase (NCT03905642) | Insmed Incorporated | 2009-01-08 |
| Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis (NCT00850551) | University of Washington | 2009-01-01 |
| Cystic Fibrosis (CF) Flow Rates Study (NCT00779077) | Syntara | 2009-01-01 |
| Cystic Fibrosis Core Strengthening and Respiratory Exercise Program (NCT00751647) | Children's Hospitals and Clinics of Minnesota | 2008-12-01 |
| Pharmacokinetics of Inhaled Mannitol in Cystic Fibrosis Patients (NCT00792714) | Syntara | 2008-12-01 |
| Cholecalciferol for Vitamin D in Adult Cystic Fibrosis (CF) Patients (NCT00685971) | Unity Health Toronto | 2008-12-01 |
| The Use of Visual Feedback in Airway Clearance (NCT01546779) | Sheba Medical Center | 2008-12-01 |
| Improvement of Aerobic Capacity in Cystic Fibrosis Patients With a One-year Home Training Period (NCT00792194) | University Hospital, Strasbourg, France | 2008-12-01 |
| Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders (NCT00846573) | University of Massachusetts, Worcester | 2008-11-01 |
| An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) (NCT00787917) | Novartis Pharmaceuticals | 2008-11-01 |
| Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection (NCT00794586) | Gilead Sciences | 2008-11-01 |
| Growth Hormone Therapy for Wasting in Cystic Fibrosis (NCT00803179) | University of Massachusetts, Worcester | 2008-11-01 |
| NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients (NCT00809094) | Stanford University | 2008-11-01 |
| Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers (NCT00800579) | Gilead Sciences | 2008-11-01 |
| An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients (NCT00765401) | Penn State University | 2008-11-01 |
| Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients (NCT01112059) | University of Alabama at Birmingham | 2008-11-01 |
| Use of a Biofilm Antimicrobial Susceptibility Assay to Guide Antibiotic Therapy (NCT00786513) | The Hospital for Sick Children | 2008-11-01 |
| Nasal Inhalation of Tobramycin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization (NCT00774072) | University of Jena | 2008-10-01 |
| Effects of Vitamin D Supplementation on Lung Function in an Acute Pulmonary Exacerbation of Cystic Fibrosis (NCT00788138) | Emory University | 2008-10-01 |
| Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung Disease (NCT00934362) | University of North Carolina, Chapel Hill | 2008-10-01 |
| Long-term Study, Comparing Vest Therapy to Positive Expiratory Pressure (PEP) Therapy in the Treatment of Cystic Fibrosis (NCT00817180) | University of British Columbia | 2008-10-01 |
| Omega 3 Supplementation in Cystic Fibrosis Patients (NCT00959010) | Queen Fabiola Children's University Hospital | 2008-10-01 |
| A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis (NCT00757848) | AstraZeneca | 2008-10-01 |
| Long Term Administration of Inhaled Mannitol in Cystic Fibrosis (NCT00630812) | Syntara | 2008-09-01 |
| Early Assessment of Respiratory Function, Inflammation and Bronchial Reshuffle Among Newborns Screened for Cystic Fibrosis (NCT02883816) | University Hospital, Montpellier | 2008-08-01 |
| Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa (NCT00757237) | Gilead Sciences | 2008-08-01 |
| Transfer Impedance in Cystic Fibrosis (NCT00743158) | Boston Children's Hospital | 2008-08-01 |
| A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency (NCT00662675) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-08-01 |
| Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease (NCT00659529) | National Jewish Health | 2008-08-01 |
| Efficacy of Bucelipase Alfa (BSSL) in Patients With Cystic Fibrosis and Pancreatic Insufficiency (NCT00743483) | Swedish Orphan Biovitrum | 2008-08-01 |
| Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb® Compared to Placebo Control (NCT00744250) | Digestive Care, Inc. | 2008-08-01 |
| Miglustat in Cystic Fibrosis (NCT00742092) | Actelion | 2008-08-01 |
| Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients (NCT00669760) | University Hospital Muenster | 2008-07-01 |
| Leucine-enriched Essential Amino Acid Intake to Optimize Protein Anabolism in Children With Cystic Fibrosis (NCT01172301) | Texas A&M University | 2008-07-01 |
| Exercise-Induced Bronchospasm in Cystic Fibrosis (NCT00806455) | Ohio State University | 2008-07-01 |
| Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis (NCT00706004) | University of Arkansas | 2008-07-01 |
| Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF) (NCT00690820) | Solvay Pharmaceuticals | 2008-06-01 |
| Do Physiotherapy Techniques Improve Posture During Admission for a Chest Infection in Adults With Cystic Fibrosis? (NCT00806884) | Royal Brompton & Harefield NHS Foundation Trust | 2008-06-01 |
| IGF-1 Therapy in Patients With Cystic Fibrosis (NCT00566241) | Stony Brook University | 2008-06-01 |
| Scandinavian Cystic Fibrosis Azithromycin Study (NCT00411736) | Rigshospitalet, Denmark | 2008-05-01 |
| Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis (NCT00645788) | Bayer | 2008-05-01 |
| Comparison of Airway Clearance Therapy in Cystic Fibrosis Using the Same VEST Therapy Device But With Different Settings (NCT00685035) | University of Minnesota | 2008-05-01 |
| Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF) (NCT00670579) | University of Florence | 2008-05-01 |
| Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis, Mild Lung Disease, and P. Aeruginosa (NCT00712166) | Gilead Sciences | 2008-05-01 |
| Changes in Adherence After Playing "My Life With CF" Game (NCT00688051) | Children's Mercy Hospital Kansas City | 2008-05-01 |
| 18FDG-PET Imaging to Detect Changes in Airways Inflammation in Cystic Fibrosis Patients (NCT00684346) | The Hospital for Sick Children | 2008-04-01 |
| Modulation by Sex Hormones of Inflammation and Susceptibility to Pseudomonas Aeruginosa in Cystic Fibrosis Airways (NCT00700050) | The Hospital for Sick Children | 2008-04-01 |
| Nutritional, Metabolic and Respiratory Status in Cystic Fibrosis (NCT00476281) | University Hospital, Strasbourg, France | 2008-04-01 |
| Doxycycline Effects on Inflammation in Cystic Fibrosis (NCT01323101) | University of Southern California | 2008-04-01 |
| Comprehensive Exercise Training Program During Hospitalization for an Acute CF Exacerbation (NCT01759342) | University of Alabama at Birmingham | 2008-04-01 |
| Self-dispersing Liquids as Aerosol Drug Carriers (NCT00628134) | University of Pittsburgh | 2008-03-01 |
| NPD Measurement in Infants (NCT00564304) | Hadassah Medical Organization | 2008-03-01 |
| Vitamin D3 for the Treatment of Low Vitamin D in Cystic Fibrosis (NCT00762918) | Children's Hospital of Philadelphia | 2008-03-01 |
| The Effect of Hypertonic Saline on the Lung Clearance Index in Patients With Cystic Fibrosis (NCT00635141) | The Hospital for Sick Children | 2008-03-01 |
| Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa (NCT00638365) | Humanigen, Inc. | 2008-03-01 |